Evidence map›Paper›PMID 36130222›Full record

Trial reportThe American journal of clinical nutrition2022

The impact of almonds and almond processing on gastrointestinal physiology, luminal microbiology, and gastrointestinal symptoms: a randomized controlled trial and mastication study.

Alice C Creedon, Eirini Dimidi, Estella S Hung, Megan Rossi, Christopher Probert, Terri Grassby, Jesus Miguens-Blanco, Julian R Marchesi, S Mark Scott, Sarah E Berry and 1 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03581812 (Snack Foods and Their Impact on Gastrointestinal Physiology, Luminal Microbiology and Gastrointestinal Symptoms), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03581812 nacompletednot on this map

Snack Foods and Their Impact on Gastrointestinal Physiology, Luminal Microbiology and Gastrointestinal Symptoms

TypeinterventionalSponsorKing's College LondonRan2018 to 2019Enrolled87ConditionsHuman Microbiome, Eating BehaviorArmsIntervention snack 1, Intervention snack 2, Control snack
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Alice C CreedonDepartment of Nutritional Sciences, King's College London, London, United Kingdom.ORCID 0000-0001-5054-1786
Eirini DimidiDepartment of Nutritional Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-0140-0199
Estella S HungDepartment of Nutritional Sciences, King's College London, London, United Kingdom.
Megan RossiDepartment of Nutritional Sciences, King's College London, London, United Kingdom.
Christopher ProbertDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0003-4550-0239
Terri GrassbyDepartment of Nutritional Sciences, University of Surrey, Guildford, United Kingdom.ORCID 0000-0002-0658-9093
Jesus Miguens-BlancoDivision of Digestive Diseases, Imperial College London, London, United Kingdom.ORCID 0000-0001-7725-965X
Julian R MarchesiDivision of Digestive Diseases, Imperial College London, London, United Kingdom.ORCID 0000-0002-7994-5239
S Mark ScottDepartment of Neuroscience, Surgery and Trauma, Blizard Institute, Queen Mary University of London, London, United Kingdom.
Sarah E BerryDepartment of Nutritional Sciences, King's College London, London, United Kingdom.
Kevin WhelanDepartment of Nutritional Sciences, King's College London, London, United Kingdom.ORCID 0000-0001-5414-2950
King's College London · GBImperial College London · GBQueen Mary University of London · GBUniversity of Liverpool · GBUniversity of Surrey · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlmonds contain lipid, fiber, and polyphenols and possess physicochemical properties that affect nutrient bioaccessibility, which are hypothesized to affect gut physiology and microbiota.

objectivesTo investigate the impact of whole almonds and ground almonds (almond flour) on fecal bifidobacteria (primary outcome), gut microbiota composition, and gut transit time.

methodsHealthy adults (n = 87) participated in a parallel, 3-arm randomized controlled trial. Participants received whole almonds (56 g/d), ground almonds (56 g/d), or an isocaloric control in place of habitual snacks for 4 wk. Gut microbiota composition and diversity (16S rRNA gene sequencing), SCFAs (GC), volatile organic compounds (GC-MS), gut transit time (wireless motility capsule), stool output and gut symptoms (7-d diary) were measured at baseline and endpoint. The impact of almond form on particle size distribution (PSD) and predicted lipid release was measured (n = 31).

resultsModified intention-to-treat analysis was performed on 79 participants. There were no significant differences in mean ± SD abundance of fecal bifidobacteria after consumption of whole almonds (8.7% ± 7.7%), ground almonds (7.8% ± 6.9%), or control (13.0% ± 10.2%; q = 0.613). Consumption of almonds (whole and ground pooled) resulted in higher mean ± SD butyrate (24.1 ± 15.0 μmol/g) than control (18.2 ± 9.1 μmol/g; P = 0.046). There was no effect of almonds on gut microbiota at the phylum level or diversity, gut transit time, stool consistency, or gut symptoms. Almond form (whole compared with ground) had no effect on study outcomes. Ground almonds resulted in significantly smaller PSD and higher mean ± SD predicted lipid release (10.4% ± 1.8%) than whole almonds (9.3% ± 2.0%; P = 0.017).

conclusionsAlmond consumption has limited impact on microbiota composition but increases butyrate in adults, suggesting positive alterations to microbiota functionality. Almonds can be incorporated into the diet to increase fiber consumption without gut symptoms.This trial was registered at clinicaltrials.gov as NCT03581812.

Indexed as

Prunus dulcisAdultBifidobacteriumButyratesFecesHumansMasticationRNA, Ribosomal, 16SButyratesRNA, Ribosomal, 16Salmondsbifidobacteriabutyrategut microbiotagut transit timemasticationparticle sizeSCFA

Identifiers

PMID36130222
PMCPMC9761756
OpenAlexW4296974302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.